Issue Special Issue 1/2011
Differential use of CCR5 versus CXCR4 by HIV-1. Pathogenic, Translational and Clinical Open Questions
Content (11 Articles)
Open Access
Introduction
Introducing the issue on “Differential use of CCR5 versus CXCR4 by HIV-1. Pathogenic, Translational and Clinical Open Questions”
Guido Poli, Luigi Buonaguro
Open Access
Review
Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
Maria Tagliamonte, Maria Lina Tornesello, Franco M Buonaguro, Luigi Buonaguro
Open Access
Review
HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV
Claudia Cicala, James Arthos, Anthony S Fauci
Open Access
Review
R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies
Lamorris M Loftin, Martha Kienzle, Yanjie Yi, Ronald G Collman
Open Access
Review
Clinical significance of HIV-1 coreceptor usage
Hanneke Schuitemaker, Angélique B van 't Wout, Paolo Lusso
Open Access
Review
Selective transmission of R5 HIV-1 variants: where is the gatekeeper?
Jean-Charles Grivel, Robin J Shattock, Leonid B Margolis
Open Access
Review
Coreceptor use in nonhuman primate models of HIV infection
Silvana Tasca Sina, Wuze Ren, Cecilia Cheng-Mayer
Open Access
Review
Asymmetric HIV-1 co-receptor use and replication in CD4+ T lymphocytes
Samanta A Mariani, Elisa Vicenzi, Guido Poli
Open Access
Review
Clinical use of CCR5 inhibitors in HIV and beyond
Bruce L Gilliam, David J Riedel, Robert R Redfield
Open Access
Review
HIV-1 co-receptor usage:influence on mother-to-child transmission and pediatric infection
Mariangela Cavarelli, Gabriella Scarlatti